High molecular weight hyaluronic acid inhibits IL-6-induced MMP production from human chondrocytes by up-regulating the ERK inhibitor, MKP-1

被引:62
作者
Hashizume, Misato [1 ]
Mihara, Masahiko [1 ]
机构
[1] Chugai Pharmaceut Co Ltd, Prod Res Dept, Fuji Gotemba Res Labs, Shizuoka 4128513, Japan
关键词
High molecular weight hyaluronic acid; IL-6; Matrix metalloproteinase; MKP-1; ERK1/2; INTERCELLULAR-ADHESION MOLECULE-1; NF-KAPPA-B; RHEUMATOID SYNOVIAL FIBROBLASTS; CELL-SURFACE RECEPTOR; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE; DOWN-REGULATION; OSTEOARTHRITIS; INTERLEUKIN-6; KINASE;
D O I
10.1016/j.bbrc.2010.10.135
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To investigate the mechanism of the inhibitory action of high molecular weight hyaluronic acid (HA) on production of matrix metalloproteinases (MMPs) induced by IL-6 in human chondrocyte. Human chondrocyte were stimulated by interleukin-6 (IL-6) and soluble IL-6 receptor (sIL-6R) with or without HA for 24 h and the productions of MMP-1, MMP-3 and MMP-13 were measured. Phosphorylations of extracellular signal-regulated kinase (ERK), signal transducer and activator of transcription (STAT) and mitogen-activated protein kinase kinase (MEK) in 1L-6 + sIL-6R-treated chondrocytes were detected by western blotting. IL-6 + sIL-6R induced MMP-I, MMP-3 and MMP-13 productions from human chondrocyte. Inhibition of the mitogen-activated protein kinase (MAPK) signaling pathway resulted in marked decreases of MMP-1, MMP-3 and MMP-13,induction by 1L-6. In contrast, STAT inhibition only slightly attenuated the production of MMPs. HA inhibited MMP-1, MMP-3 and MMP-13 induction by IL-6, which was reversed by the addition of anti-CD44 antibody but not anti-ICAM-1 antibody. Pre-treatment of cells with HA reduced the phosphorylation of ERK, but not MEK. Expression levels of mitogen-activated protein kinase phosphatase-1 (MKP-1) in HA-treated chondrocytes were assessed by western blotting. HA induced the expression of MKP-1, a negative regulator of ERK1/2 in IL-6 + sIL-6R-treated or untreated chondrocytes, and the MKP-1 inhibitor and MKP-1 siRNA reversed the HA-induced suppression of MMP induction by IL-6. Our study is the first to demonstrate that HA suppressed MMPs induction by IL-6 in human chondrocyte via MKP-1 induction through CD44 signaling. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:184 / 189
页数:6
相关论文
共 34 条
[1]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[2]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[3]   Differential effects of tumor necrosis factor-α and interleukin-1β on cell death in human articular chondrocytes [J].
Carames, B. ;
Lopez-Armada, M. J. ;
Cillero-Pastor, B. ;
Lires-Dean, M. ;
Vaamonde, C. ;
Galdo, F. ;
Blanco, F. J. .
OSTEOARTHRITIS AND CARTILAGE, 2008, 16 (06) :715-722
[4]   EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) ON HUMAN ARTICULAR-CARTILAGE CHONDROCYTES [J].
DAVIES, ME ;
DINGLE, JT ;
PIGOTT, R ;
POWER, C ;
SHARMA, H .
CONNECTIVE TISSUE RESEARCH, 1991, 26 (03) :207-216
[5]   Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4 [J].
del Fresno, C ;
Otero, K ;
Gómez-García, L ;
González-León, MC ;
Soler-Ranger, L ;
Fuentes-Prior, P ;
Escoll, P ;
Baos, R ;
Caveda, L ;
García, F ;
Arnalich, F ;
López-Collazo, E .
JOURNAL OF IMMUNOLOGY, 2005, 174 (05) :3032-3040
[6]  
Desgeorges A, 1997, J RHEUMATOL, V24, P1510
[7]   MAP kinases in the immune response [J].
Dong, C ;
Davis, RJ ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :55-72
[8]   Role of mitogen-activated protein kinases and NFκB on IL-1β-induced effects on collagen type II, MMP-1 and 13 mRNA expression in normal articular human chondrocytes [J].
Fan, Zhiyong ;
Yang, Huiqing ;
Bau, Brigitte ;
Soeder, Stephan ;
Aigner, Thomas .
RHEUMATOLOGY INTERNATIONAL, 2006, 26 (10) :900-903
[9]   Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity [J].
Goldberg, VM ;
Buckwalter, JA .
OSTEOARTHRITIS AND CARTILAGE, 2005, 13 (03) :216-224
[10]   Desirable effect of combination therapy with high molecular weight hyaluronate and NSAIDs on MMP production [J].
Hashizume, M. ;
Mihara, M. .
OSTEOARTHRITIS AND CARTILAGE, 2009, 17 (11) :1513-1518